This insight brief summarizes findings from a Leavitt Partners survey asking Congressional health policy staff about their communications and research preferences when learning about a new health policy issue. Understanding how to be effective in communicating with Congressional health policy staff is valuable knowledge for stakeholders who seek to inform and engage Congress on health … Continue reading
This brief explains how health care organizations can modernize quality reporting by using standardized, real‑time data connections that many systems already have in place. Leavitt Partners, an HMA company, facilitated discussions with the Digital Quality Implementers Community, NCQA, and several health systems to conduct a feasibility study. The findings suggest that nearly half of today’s … Continue reading
January 22, 2026 – 12pm ET CMS’s new ACCESS model represents one of the most ambitious federal efforts to modernize chronic care through technology-supported services. This national, voluntary, decade-long model creates a new payment pathway for digital health tools, continuous monitoring, behavioral support, and other tech-enabled interventions that complement traditional care. With beneficiaries able to … Continue reading
This webinar was held on December 15, 2025. Information blocking continues to hinder timely access to electronic health data for patients, providers, payers, and the federal government. While federal regulations prohibit interference with data exchange, in practice key participants across the health data landscape continue to limit access in ways that constrain care delivery, population … Continue reading
This webinar was held on December 17, 2025. In this webinar, HMA and the National Alliance for Impacting the Social Determinants of Health (NASDOH), an alliance managed by Leavitt Partners, an HMA Company, had an in-depth discussion on the evolving policy landscape on the upstream drivers of health, which includes the social, economic, and environmental … Continue reading
Today, Leavitt Partners released a Medicare policy guide that provides an accessible overview of several major policy concepts that have circulated in Medicare reform conversations in recent years. With debate mounting over the future of Medicare, it is imperative that policymakers first understand these core policy proposals–including site neutral payments, competitive bidding in Medicare Advantage, … Continue reading
Information blocking continues to hinder timely access to electronic health data for patients, providers, payers, and the federal government. While federal regulations prohibit interference with data exchange, in practice information blocking remains largely unchecked. Because of insufficient enforcement of these regulations, data continue to be delayed or withheld from patients, clinicians, payers, and networks–resulting in … Continue reading
Leavitt Partners, an HMA Company, is pleased to announce that Elaine Lippmann, J.D., has joined the firm as a principal, located in Washington, D.C. Lippmann joins recently hired former U.S. Food and Drug Administration (FDA) leader Julie Tierney on an expert team of health policy and government affairs consultants at Leavitt Partners. Collectively, our bipartisan … Continue reading
THE CURRENT ENVIRONMENT Life science organizations and other stakeholders impacted by the U.S. Food and Drug Administration (FDA) face exciting opportunities and demanding challenges, operating at the nexus of cutting-edge science, patient needs, and evolving regulatory requirements while facing political and regulatory scrutiny. Novel therapies, including those created through advancements in cell and gene therapies, … Continue reading
Leavitt Partners, an HMA Company, is pleased to announce that Julie Tierney has joined the company’s team of health policy experts as a principal, located in Washington, D.C. Tierney is a proven executive with more than 20 years of FDA legal, policy, and operational experience. She held a number of senior roles at FDA, including … Continue reading
